Brought to you by 
Discovery Partners and Infinity merge
15 Sep 2006
Executive Summary
Public drug discovery services company Discovery Partners International (DPI) and Infinity Pharmaceuticals (small-molecule cancer therapeutics) have merged to form a new entity under the Infinity name that will be focused on cancer drug discovery and development.
Deal Industry
- Pharmaceuticals
- Services
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Stock
- Reverse Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Discovery Partners and Infinity merge
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice